Thymoglobulin (Anti-Thymocyte Globulin Drug Interactions
Thymoglobulin (Anti-Thymocyte Globulin (Rabbit)) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Thymoglobulin. Always confirm against the full prescribing information.
100 interactions
Anthrax immune globulin human
The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Antithymocyte immunoglobulin (rabbit).
Level 2 evidence
AstraZeneca COVID-19 Vaccine
The therapeutic efficacy of AstraZeneca COVID-19 Vaccine can be decreased when used in combination with Antithymocyte immunoglobulin (rabbit).
The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Antithymocyte immunoglobulin (rabbit).
The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Antithymocyte immunoglobulin (rabbit).
The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Antithymocyte immunoglobulin (rabbit).
Level 2 evidence
Denosumab
The risk or severity of adverse effects can be increased when Denosumab is combined with Antithymocyte immunoglobulin (rabbit).
Level 1 evidence
Aducanumab
The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Aducanumab.
Level 2 evidence
Alirocumab
The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Alirocumab.
Level 2 evidence
Allogeneic processed thymus tissue
The therapeutic efficacy of Allogeneic processed thymus tissue can be decreased when used in combination with Antithymocyte immunoglobulin (rabbit).
Level 2 evidence
Amivantamab
The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Amivantamab.
Level 2 evidence
Ansuvimab
The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Ansuvimab.
Level 2 evidence
Anthrax vaccine
The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Antithymocyte immunoglobulin (rabbit).
Level 1 evidence
Enter your NPI to unlock 66 major interactions for Thymoglobulin
Thymoglobulin (Anti-Thymocyte Globulin (Rabbit)) has 380 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Thymoglobulin (Anti-Thymocyte Globulin (Rabbit)) has 219 major, 38 moderate, and 123 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Thymoglobulin. Always confirm against the full prescribing information.